MiyaresMA. Comment: efficacy and safety of argatroban and bivalirudin in patients with suspected heparin-induced thrombocytopenia. Ann Pharmacother. 2015;49:499.
2.
VoQTLinJKTongLM. Efficacy and safety of argatroban and bivalirudin in patients with suspected heparin-induced thrombocytopenia. Ann Pharmacother. 2015;49:178-184.
3.
SmytheMAStephensJLKoerberJMMattsonJC. A comparison of lepirudin and argatroban outcomes. Clin Appl Thromb Hemost. 2005;11:371-374.
4.
KiserTHJungRMacLarenRFishDN. Evaluation of diagnostic tests and argatroban or lepirudin therapy in patients with suspected heparin-induced thrombocytopenia. Pharmacotherapy. 2005;25:1736-1745.
5.
SkrupkyLPSmithJRDealEN. Comparison of bivalirudin and argatroban for the management of heparin-induced thrombocytopenia. Pharmacotherapy. 2010;30:1229-1238.
